九源基因_Providing professional financial news and data related to 九源基因, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
Marketingforce Management(02556.HK): Profit Forecast, Interim Revenue from AI Application Business Expected to Surge 112% to 134%
Finance
Hengrui Pharmaceuticals(01276.HK): Concentrated Solution for Injection HRS-8829 Receives Clinical Trial Approval Notice
Finance
MicroPort Scientific (00853.HK): Proposed Disposal of Controlling Stake in MicroPort Orthopedics (Shanghai) to Tinavi Medical
Finance
Renrui Human Resources(06919.HK): Non-executive Director Wang Xinjie Resigns; Gao Yunjie Appointed
Finance
Ubox Online (02429.HK): Full Circulation of H Shares Approved by HKEX
Finance
Chengdu Expressway (01785.HK): Signs Precast Concrete Component Procurement Contract for Chengdu-Wenjiang-Qionglai Expressway Expansion Project Worth Approximately RMB 234 Million
Finance
Prinx Chengshan (01809.HK): CEO Reshuffle – Che Baozhen Steps Down, Jiang Xizhou Appointed as President
Finance
Fameglow Holdings(03774.HK): Enters Technology Development Agreement with Sunseeker to Jointly Develop AI Anti-Aging Platform
Finance
Zhongtai Futures (01461.HK): Positive Profit Alert, Interim Net Profit Attributable to Parent Expected to Rise 190% to 210%
Finance
InnoCare Pharma Limited(09969.HK): Phase III Registrational Trial of Soficitinib (ICP-332) for Moderate-to-Severe Atopic Dermatitis Meets Primary Endpoint Successfully

Scan QR Code

Download App